EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE ON INTRATHORACIC AND LEFT-VENTRICULAR TRANSMURAL PRESSURES IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:318
|
作者
NAUGHTON, MT
RAHMAN, MA
HARA, K
FLORAS, JS
BRADLEY, TD
机构
[1] UNIV TORONTO,TORONTO HOSP,CARDIOVASC RES CTR,DEPT MED,DIV RESPIROL,TORONTO,ON M5G 2C4,CANADA
[2] UNIV TORONTO,TORONTO HOSP,CARDIOVASC RES CTR,DEPT MED,DIV CARDIOL,TORONTO,ON M5G 2C4,CANADA
关键词
VENTRICLES; PRESSURE; HEART FAILURE;
D O I
10.1161/01.CIR.91.6.1725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Continuous positive airway pressure (CPAP) can improve cardiac function in patients with congestive heart failure (CHF). We hypothesized that this effect might be related to CPAP-induced increases in intrathoracic pressure, which would reduce left ventricular transmural pressure (LVP(tm)) during systole, thereby decreasing left ventricular afterload. Methods and Results The effect of graduated CPAP from 0 to 10 cm H2O on the above variables was examined over a 75-minute period and compared with a 75-minute time control period without CPAP in two groups of subjects: 15 patients with CHF and 9 healthy subjects. Intrathoracic pressure was estimated from esophageal pressure (P-es), and systolic LVP(tm), a determinant of left ventricular afterload, was assessed by subtracting P-es during systole from systolic blood pressure. Cardiac index (CI) was assessed by Doppler echocardiography. At baseline, inspiratory P-es amplitude, which reflects inspiratory muscle force generation, was greater in the patients with CHF than in the healthy group (9.9+/-0.8 versus 5.5+/-0.4 mm Hg, P<.001). In addition, systolic P-es, which represents the relative contribution of intrathoracic pressure to LVP(tm), was more negative in the patients with CHF than in the healthy group (-4.1+/-0.3 versus -2.2+/-0.1 mm Hg, P<.001). While on CPAP of 10 cm H2O, inspiratory P-es amplitude decreased and systolic P-es increased significantly in the group with CHF (from 11.1+/-1.1 to 7.5+/-1.1 mm Hg, P<.025 and from -4.7+/-0.6 to 0.6+/-0.6 mm Hg, P<.001, respectively), but CPAP had no effect on these variables in the healthy subjects. Compared with the equivalent time control period, P-es amplitudeXrespiratory rate decreased significantly while on CPAP in both the group with CHF (from 188+/-22 to 112+/-17 mm HgXbreaths per minute, P<.005) and the healthy group (from 82+/-8 to 60+/-6 mm HgXbreaths per minute, P<.05). Compared with time control, systolic LVP(tm) decreased significantly while on CPAP, from 116.0+/-5.3 to 110.3+/-4.5 mm Hg (P<.025) in the group with CHF, but did not change in the healthy group. Moreover, systolic LVP(tm)Xheart rate decreased significantly in the group with CHF (from 80.55+/-5.27 to 71.83+/-4.73 mm HgXbeats per minute/100, P<.005) but not in the healthy group. CI decreased significantly while on CPAP in the healthy group (P<.025) but did not change in the group with CHF. Conclusions In patients with CHF, the inspiratory muscles generate greater force per breath and systolic P-es contributes more to LVP(tm) than in healthy subjects. By increasing intrathoracic pressure in patients with CHF, CPAP unloaded inspiratory muscles and reduced left ventricular afterload without compromising CI.
引用
收藏
页码:1725 / 1731
页数:7
相关论文
共 50 条
  • [21] THE EFFECTS OF POSTURE CHANGE AND CONTINUOUS POSITIVE AIRWAY PRESSURE ON CARDIAC NATRIURETIC PEPTIDES IN CONGESTIVE-HEART-FAILURE
    WILKINS, MA
    SU, XL
    PALAYEW, MD
    YAMASHIRO, Y
    BOLLI, P
    MCKENZIE, JK
    KRYGER, MH
    CHEST, 1995, 107 (04) : 909 - 915
  • [22] EFFECTS OF FELODIPINE ON LEFT-VENTRICULAR SYSTOLIC AND DIASTOLIC PERFORMANCE IN CONGESTIVE-HEART-FAILURE
    CHENG, CP
    PETTERSSON, K
    LITTLE, WC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (03): : 1409 - 1417
  • [23] LEFT-VENTRICULAR DIASTOLIC DYSFUNCTION AS A CAUSE OF CONGESTIVE-HEART-FAILURE - MECHANISMS AND MANAGEMENT
    BONOW, RO
    UDELSON, JE
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (06) : 502 - 510
  • [24] COMPARISON OF NEUROENDOCRINE ACTIVATION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION WITH AND WITHOUT CONGESTIVE-HEART-FAILURE - A SUBSTUDY OF THE STUDIES OF LEFT-VENTRICULAR DYSFUNCTION (SOLVD)
    FRANCIS, GS
    BENEDICT, C
    JOHNSTONE, DE
    KIRLIN, PC
    NICKLAS, J
    LIANG, CS
    KUBO, SH
    RUDINTORETSKY, E
    YUSUF, S
    CIRCULATION, 1990, 82 (05) : 1724 - 1729
  • [25] DEVELOPMENT OF CONGESTIVE-HEART-FAILURE AND ALTERATIONS IN LEFT-VENTRICULAR FUNCTION IN PATIENTS WITH SUSTAINED VENTRICULAR TACHYARRHYTHMIAS TREATED WITH AMIODARONE
    DEPAOLA, AAV
    HOROWITZ, LN
    SPIELMAN, SR
    BRADY, P
    MORGANROTH, J
    GREENSPAN, AM
    KAY, HR
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (04): : 276 - 280
  • [26] EFFECT OF MILRINONE ON VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    FERRICK, KJ
    FEIN, SA
    FERRICK, AM
    KEANE, AT
    WRIGHT, EM
    DOYLE, JT
    BIDDLE, TL
    CIRCULATION, 1986, 74 (04) : 508 - 508
  • [27] CONGESTIVE-HEART-FAILURE SYMPTOMS IN PATIENTS WITH PRESERVED LEFT-VENTRICULAR SYSTOLIC FUNCTION - ANALYSIS OF THE CASS REGISTRY
    JUDGE, KW
    PAWITAN, Y
    CALDWELL, J
    GERSH, BJ
    KENNEDY, JW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) : 377 - 382
  • [28] LEFT-VENTRICULAR MASS INDEX IS INCREASED IN CONGESTIVE-HEART-FAILURE PATIENTS WITH ELEVATED CONCENTRATIONS OF ENDOGENOUS OUABAIN
    SILVERMAN, ME
    PLOTNICK, GD
    WEINBERG, M
    KRICHTEN, CM
    HEINE, D
    HAMLYN, JM
    GOTTLIEB, SS
    CLINICAL RESEARCH, 1992, 40 (03): : A665 - A665
  • [29] SHORT-TERM PROGNOSIS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE AND NORMAL LEFT-VENTRICULAR SYSTOLIC FUNCTION
    ROEL, JE
    BOUZA, G
    LANTOS, J
    CIFRE, JR
    BRUNO, C
    FALCON, JL
    MEDICINA-BUENOS AIRES, 1993, 53 (05) : 385 - 390
  • [30] EFFECTS OF ATRIOPEPTIDASE INHIBITOR UK 79300 ON LEFT-VENTRICULAR HYDRAULIC LOAD IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    KROMER, EP
    ELSNER, D
    KAHLES, HW
    RIEGGER, GAJ
    AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (05) : 460 - 463